Cargando…
MELK is a novel therapeutic target in high-risk neuroblastoma
Maternal embryonic leucine zipper kinase (MELK) is known to modulate intracellular signaling and control cellular processes. However, the role of MELK in oncogenesis is not well defined. In this study, using two microarray datasets of neuroblastoma (NB) patients, we identified that MELK expression i...
Autores principales: | Guan, Shan, Lu, Jiaxiong, Zhao, Yanling, Yu, Yang, Li, Hui, Chen, Zhenghu, Shi, Zhongcheng, Liang, Haoqian, Wang, Mopei, Guo, Kevin, Chen, Xiangmei, Sun, Wenjing, Bieerkehazhi, Shayahati, Xu, Xin, Sun, Surong, Agarwal, Saurabh, Yang, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788662/ https://www.ncbi.nlm.nih.gov/pubmed/29416794 http://dx.doi.org/10.18632/oncotarget.23515 |
Ejemplares similares
-
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis
por: Guan, Shan, et al.
Publicado: (2017) -
Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis
por: Guan, Shan, et al.
Publicado: (2016) -
Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
por: Chen, Zhenghu, et al.
Publicado: (2016) -
Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo
por: Chen, Zhenghu, et al.
Publicado: (2017) -
Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling
por: Bieerkehazhi, Shayahati, et al.
Publicado: (2016)